PrimeGen US, Inc. (“PrimeGen US" or the "Company”), a pioneering biotech company advancing innovative stem cell and exosome ...
Azenta (NASDAQ:AZTA) reported fiscal first-quarter 2026 revenue of $149 million, up 1% on a reported basis but down 1% ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results